Skip to main content
. 2020 May 21;64(6):e02415-19. doi: 10.1128/AAC.02415-19

FIG 2.

FIG 2

Antimicrobial activity of carbapenem-ZN148 combinations. (A) Cumulative meropenem (MEM) MIC alone or in combination with 50 μM ZN148 against MBL-producing E. coli (n = 112), K. pneumoniae (n = 112), and other Enterobacterales (n = 10) and all strains (n = 234) combined. (B) Cumulative doripenem (DOR) and imipenem (IPM) MIC alone or in combination with 50 μM ZN148, against MBL-producing E. coli (n = 87) and MBL-producing K. pneumoniae (n = 85). (C) Cumulative meropenem (MEM), doripenem (DOR), and imipenem (IPM) MIC alone or in combination with 50 μM ZN148 against MBL-producing P. aeruginosa. For MEM the collection included 61 strains, while for DOR and IPM the collection included 52 strains.